Your browser doesn't support javascript.
loading
Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma.
Meirson, Tomer; Neiman, Victoria; Sternschuss, Michal; Markel, Gal; Tannock, Ian F.
Afiliação
  • Meirson T; Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel. Electronic address: tomermrsn@gmail.com.
  • Neiman V; Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel.
  • Sternschuss M; Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel.
  • Markel G; Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Tannock IF; Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Lancet Oncol ; 23(11): e489, 2022 11.
Article em En | MEDLINE | ID: mdl-36328018
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article